U.S. Announces Ban on CFC Asthma Inhalers

U.S. asthma sufferers who use asthma inhalers with ozone-depleting chlorofluorocarbons (CFCs) are urged to talk to their doctors now about switching to a an albuterol inhaler that contains hydrofluroalkane (HFA) propellants instead. CFC inhalers will be banned starting in January.

Asthma patients are advised to switch now, because there are differences between CFA and HFA inhalers that will take time to get used to.

Only Armstron Pharmaceuticals still sells an albuterol CFC inhaler, so most patients will have switched to the new HFA type.

Read the full story here: U.S. alerts asthma patients about inhaler switch (from Reuters).